About Tetratricopeptide repeat protein 6
Tetratricopeptide repeat protein 6 (TTC6) is a protein
from Homo sapiens identified by UniProt accession
Q86TZ1, 520 residues long.
MolForge cross-references it against 0 known binders and
86 disease associations.
Target properties
| Protein name | Tetratricopeptide repeat protein 6 |
| UniProt accession | Q86TZ1 |
| Gene | TTC6 |
| Organism | Homo sapiens |
| Length | 520 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (86)
Diseases linked to this target (Open Targets).
- allergic disease · score 0.37
- prostate carcinoma · score 0.31
- allergic rhinitis · score 0.30
- neurodegenerative disease · score 0.27
- gut microbiome measurement · score 0.27
- eosinophil count · score 0.23
- Parkinson disease · score 0.18
- urate measurement · score 0.18
- eosinophil percentage of leukocytes · score 0.18
- Meckel syndrome · score 0.11
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86TZ1-F1 | alphafold | PREDICTED | 91.83 | — |
Amino-acid sequence (520 residues)
MMKYYDLAKF TIYQIAEMDK GLSELSPMQQ ALIYSFCENH DKAIEVLDGI SWNRAEMTMC ALLAKVQMKA KRTKEAVEVL KKALDAISHS DKGPDATAIS ADCLYNLGLC YMEEGNLQMT YKLAITDLTT AISMDKNSYT AFYNRALCYT KIRELQMALT DYGIVLLLDA TETVKLNTFL NRGLIYVELG QYGFALEDFK QAALISRTNG SLCHATAMCH HRINEFEEAV NFFTWALKIN PCFLDAYVGR GNSYMEYGHD EATKQAQKDF LKALHINPAY IKARISFGYN LQAQGKFQKA WNHFTIAIDT DPKNYLAYEG RAVVCLQMGN NFAAMQDINA AMKISTTAEF LTNRGVIHEF MGHKQNAMKD YQDAITLNPK YSLAYFNAGN IYFHHRQFSQ ASDYFSKALK FDPENEYVLM NRAITNTILK KYEEAKEDFA NVIESCPFWA AVYFNRAHFY YCLKQYELAE EDLNKALSLK PNDALVYNFR AKVRGKIGLI EEAMADYNQA LDLEDYASVI
Explore Tetratricopeptide repeat protein 6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets